BioHiTech Global Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BioHiTech Global stock.
View analyst ratings for BioHiTech Global or view top-rated stocks.

Wall Street analysts have given BioHiTech Global a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BioHiTech Global wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

BioHiTech Global saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 829,200 shares, an increase of 62.0% from the June 30th total of 511,900 shares. Based on an average trading volume of 549,100 shares, the days-to-cover ratio is presently 1.5 days. Currently, 3.5% of the company's stock are short sold.
View BioHiTech Global's Short Interest.

BioHiTech Global is scheduled to release its next quarterly earnings announcement on Monday, August 16th 2021.
View our earnings forecast for BioHiTech Global.

BioHiTech Global, Inc. (NASDAQ:BHTG) issued its earnings results on Monday, May, 17th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.02. The firm earned $3.04 million during the quarter.
View BioHiTech Global's earnings history.

BioHiTech Global's stock was trading at $1.71 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BHTG shares have decreased by 19.9% and is now trading at $1.37.
View which stocks have been most impacted by COVID-19.

1 Wall Street analysts have issued 1 year price targets for BioHiTech Global's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate BioHiTech Global's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 192.0% from the stock's current price.
View analysts' price targets for BioHiTech Global or view top-rated stocks among Wall Street analysts.

Some companies that are related to BioHiTech Global include Lixiang Education (LXEH), Boxlight (BOXL), Tarena International (TEDU), Sunlands Technology Group (STG), ATA Creativity Global (AACG), First High-School Education Group (FHS), RYB Education (RYB), Zovio (ZVO), OneSmart International Education Group (ONE), RISE Education Cayman (REDU), China Online Education Group (COE), Puxin (NEW), Meten EdtechX Education Group (METX), LAIX (LAIX) and CIBT Education Group (MBAIF).
View all of BHTG's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other BioHiTech Global investors own include OPKO Health (OPK), Ampio Pharmaceuticals (AMPE), Bellicum Pharmaceuticals (BLCM), Sorrento Therapeutics (SRNE), Biocept (BIOC), Bionano Genomics (BNGO), Citius Pharmaceuticals (CTXR), Palatin Technologies (PTN), Trevena (TRVN) and T2 Biosystems (TTOO).

BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG."

Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BHTG stock can currently be purchased for approximately $1.37.

BioHiTech Global has a market capitalization of $38.84 million and generates $5.88 million in revenue each year. The company earns $-11,540,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis.

BioHiTech Global employs 42 workers across the globe.

The official website for BioHiTech Global is www.biohitech.com.

BioHiTech Global is headquartered at 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977.

BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at (845) 262-1081 or via email at [email protected]